Try our Advanced Search for more refined results

Expert Analysis

SPCs — We Wait In Vain For Clarity From Europe

Law360, New York ( April 11, 2014, 12:24 PM EDT) -- In Europe, patent holders can obtain compensation for regulatory delays in bringing a new medicinal product to market via the award of a supplementary protection certificate ("SPC"), which provides a limited extension to the term of a patent protecting the product. The system was intended to be clear and easy to implement; the reality has been somewhat different and so more than 20 years after SPCs were first available, courts and practitioners remain unsure as to how key terms in the legislation are to be interpreted....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!